1. Modernizing
Healthcare for
the New Age
1ST ANNUAL UCLA HBA HEALTHCARE CONFERENCE
FRIDAY, FEBRUARY 13, 2015
UCLA CARNASALE COMMONS
http://on.fb.me/1DKCF7M
http://linkd.in/1Icq2sp
#UCLAModernHealth2015
andersonhba.com
CONNECT WITH US!

2. 2 | HBA Healthcare Conferece
» WELCOME FROM THE DEAN
» WELCOME FROM HBA PRESIDENT
Welcome to the inaugural UCLA HBA Healthcare Conference, beginning a tradition that we envision as
an annual event.
This first edition focuses on “Modernizing Healthcare for the New Age.” UCLA is the ideal setting for an
interdisciplinary healthcare summit. Beyond the resources available at Anderson, UCLA features world-
class professional schools in medicine, public policy, public health, engineering, life sciences, and nursing,
offering unique opportunities to exploit broad expertise from across campus. There are vital life, and
market-changing opportunities and challenges in healthcare today, including shrinking reimbursement
rates, expensive yet transformative biologics, declines in federal funding of research, care for a growing aging population,
breakthroughs in medical devices and personalized medicine, genomic advances and the exciting possibilities of telemedicine
and mobile health.
Today’s conference will do a deep dive into all of these topics, and more. I hope you come away from the day with a new lens
into these weighty and transformative opportunities.
We are privileged to welcome a stellar group of presenters and panelists from both UCLA and other healthcare organizations.
And please let me acknowledge (and brag about) the student organizers from UCLA Anderson’s Healthcare Business Association.
They recognized the need for today’s conference, seized the initiative, and poured energy into this conference. But of course. They
Think In The Next!
Sincerely,
Judy D. Olian
Dean and John E. Anderson Chair in Management
UCLA Anderson School of Management
Dear Classmates, Alumni and Friends of UCLA Anderson:
On behalf of the Healthcare Business Association Conference Committee, as President of the HBA, I welcome
you to the 1st Annual UCLA Anderson HBA Healthcare Conference: Modernizing Healthcare for the New Age. I
am delighted that you are joining us today as I hope this event will become a long-standing tradition, not only at
Anderson, but within the greater UCLA and Los Angeles communities.
This era of healthcare is more dynamic than ever before: mobile health is attracting unprecedented
investments by private investors, personalized medicine is now a national conversation, and health reform legislation is settling in
as the new normal. This conference aims to explore the evolution of the healthcare industry and how it has, and will, adapt to meet
the needs of modern times.
Our keynote speakers, panels, and networking opportunities will allow you to join in and become a participant in this important
conversation. I hope this conference will inspire you toward greater understanding and further exploration of the topics discussed today.
I want to extend a personal thank you to our speakers and moderators for enriching the discussion with their expertise and
insights, to our sponsors for their generous support, and to UCLA Anderson’s administration for enabling us to host such a
multidisciplinary event. Finally, I would like to thank all the attendees, because without you the purpose of the event, strengthening
and educating the UCLA and Southern California healthcare communities, would not be possible.
Sincerely,
Subodh Kolla
President
Healthcare Business Association

3. Friday, February 13, 2015 | 3
» SCHEDULE
8:00 – 9:00 a.m. REGISTRATION BREAKFAST
9:00 – 9:55 a.m. WELCOME OPENING REMARKS Palisades Room A/B/C/F
Subodh Kolla, Healthcare Business Association, President
Judy Olian, Dean and John E. Anderson Chair in Management, UCLA Anderson School of Management
David Feinberg, M.D., MBA, President, UCLA Health System, CEO, UCLA Hospital System, Associate Vice Chancellor, UCLA Health Sciences
MORNING KEYNOTE Palisades Room A/B/C/F
Neil Solomon, M.D., FACP, Vice President for Quality and Care System Transformation, Blue Shield of California
10:15 – 11:00 a.m. PANEL 1: PAYER/PROVIDER Palisades Room: D/E
Maneesh Goyal (’06), Senior Vice President of Corporate Development, Welltok, Inc.
Martin Serota, M.D., Vice President and Chief Medical Officer, AltaMed Health Services
Arthur Southam, M.D., MPH, MBA, Executive Vice President of Health Plan Operations, Kaiser Foundation Health Plan, Inc.
MODERATOR: Mike Galper, MPH, Partner, PwC
PANEL 2: EMERGING MARKETS Hermosa A/B
Michele Abbott, Assistant Policy Analyst, RAND Corporation
Michael Burke, M.H.A., Director of Business Development, UCLA Center for World Health
Ninez Ponce, MPP, Ph.D., Director of the Center for Global and Immigrant Health, UCLA Fielding School of Public Health
MODERATOR: Eric Savitsky, M.D., Founder and Executive Director, UCLA Center for International Medicine
11:15 a.m. – 12:00 p.m. PANEL 3: MED-TECH/BIO-DEVICE Hermosa A/B
Paul Grand, Managing Director, RCT Ventures
Abhra Roy, M.S., MBA (’10), Vice President, Mechanical Engineering Material Science Research Development, St. Jude Medical
Meera Shier (’09), Marketing Manager, MicroVention Inc.
MODERATOR: Jennifer McCaney, Ph.D., Senior Fellow, UCLA Business of Science Center
PANEL 4: PERSONALIZED MEDICINE Palisades Room D/E
David Chang, M.D., Executive Vice President, Research and Development, and Chief Medical Officer, Kite Pharma
Sudheer Doss, Ph.D., Director, PwC
Jill Hagenkord, M.D., FCAP, Chief Medical Officer, 23andMe
Alexander Hoffmann, Ph.D., Professor, Microbiology and Immunology, UCLA, Director, Institute for Quantitative and Computational
Biosciences
MODERATOR: Eric Vilain, Ph.D., Professor of Human Genetics, Pediatrics and Urology at UCLA,
Co-Director, Institute for Society and Genetics, Chief of Medical Genetics, UCLA
12:15 – 1:15 p.m. LUNCH MIDDAY KEYNOTE Palisades Room A/B/C/F
Introduction by: Eric Esrailian, M.D., MPH, Co-Chief of the Division of Digestive Diseases, David Geffen School of Medicine at UCLA
Peter H. Diamandis, M.D., Chairman and CEO, X Prize Foundation
1:30 – 2:15 p.m. PANEL 5: MOBILE HEALTH Hermosa A/B
Ilana Muhlstein, Registered Dietitian Nutritionist, UCLA Bruin Health Improvement Program
Kourosh Parsapour, M.D., MBA, CEO, personalRN
David J. Whelan, MBA (’02), Co-Founder, STEMP Inc.
MODERATOR: Mark Schwartz, Founder, Launchpad Digital Health
PANEL 6: POLICY Palisades Room D/E
Albert Lowey-Ball, Ph.D., Health Economics and Medicaid Advisor, UC Berkeley School of Public Health
Jonathan Fielding, M.D., MPH, MBA, Director and Professor-in-Residence, UCLA Fielding School of Public Health
Wendy Schiffer, MSPH, Director of Strategic Planning, L.A. Care Health Plan
MODERATOR: Wesley Yin, Ph.D., Associate Professor, UCLA
2:30 – 3:15 p.m. PANEL 7: BIOPHARMA Hermosa A/B
Stephanie Astrow, Ph.D., MBA, Vice President of Research and Development, Response Genetics
Gunjan (Mital) Thiagarajah, MBA (’05), Marketing Director, Amgen
Brian Williams, Director, PwC
MODERATOR: Bill Comanor, Ph.D., Professor of Health Policy and Management, Professor of Economics, UC Santa Barbara
Director, Research Program on Pharmaceutical Economics and Policy, UCLA
PANEL 8: BABY BOOMER SILVER TSUNAMI Palisades Room D/E
Sandy Atkins, MPA, Vice President of Strategic Initiatives, Partners in Care Foundation
Scott Kaiser, M.D., Chief Innovation Officer, Motion Picture Television Fund
Carol Lee Thorpe, MBA, Vice President of Programs and Services, St. Barnabas Senior Services
MODERATOR: Arash Naeim, M.D., Ph.D., Chief Medical Officer of Clinical Research and Geriatric Oncologist, UCLA Health
3:30 – 4:15 p.m. CLOSING FIRESIDE CHAT Palisades Room A/B/C/F
Thomas Priselac, MPH, President and CEO, Cedars-Sinai Health System
MODERATOR: Leah Vriesman, Ph.D., MPH, MBA, Director, UCLA Executive Education in Health Policy Management
4:30 – 5:30 p.m. NETWORKING COCKTAIL RECEPTION Covel Commons Terrace

4. 4 | HBA Healthcare Conference
» KEYNOTE SPEAKER BIOGRAPHIES
» WELCOME OPENING REMARKS
JUDY D. OLIAN, PH.D.
Dean and John E. Anderson Chair in
Management
UCLA Anderson School of Management
Judy D. Olian, Ph.D., is the eighth dean of UCLA
Anderson School of Management and John E.
Anderson Chair in Management. She began her
appointment in January 2006 after serving as
dean and professor of management at the Smeal College of Business
Administration at Pennsylvania State University, and professor and
senior associate dean at the Smith School at the University of Maryland.
Under her leadership, UCLA Anderson has hired a record number of
faculty, launched new global degree and certificate programs, and
initiated and developed targeted partnerships in Asia and Latin
America. Recently, UCLA Anderson transitioned into a new financial
model for the University of California. Under her leadership, the School
has raised almost $200 million to support innovative programming
and management thought leadership, and to advance UCLA Anderson
as one of the leading schools of management in the world.
Dean Olian leads a school that annually provides management
education to almost 2,000 students and to more than 2,000
professionals through executive education programs. The school has
several widely recognized research centers and a global alumni
network of more than 35,000 graduates.
She is a sought-after speaker and has consulted for major
corporations. She serves on the advisory boards of Catalyst, the U.S.
Studies Centre at the University of Sydney, the Westwood
Technology Transfer and Ares Management.
Dean Olian holds an undergraduate degree from the Hebrew
University, Jerusalem, and a Ph.D. from the University of
Wisconsin, Madison.
DAVID T. FEINBERG, M.D., MBA
President, UCLA Health System, CEO,
UCLA Hospital System, Associate Vice
Chancellor, UCLA Health Sciences
Dr. David T. Feinberg has been CEO of UCLA’s
hospitals and associate vice chancellor of UCLA
Health Sciences since 2007. In July 2011, he
assumed the position of president of UCLA
Health System, overseeing its four hospitals — Ronald Reagan UCLA
Medical Center, Stewart and Lynda Resnick Neuropsychiatric
Hospital at UCLA, Mattel Children’s Hospital UCLA and UCLA
Medical Center, Santa Monica — and the UCLA Faculty Practice
Group. Each year, UCLA’s hospitals treat more than 40,000 patients,
and 1.5 million patients are seen in UCLA’s 150 community offices.
Ronald Reagan UCLA Medical Center and UCLA Medical Center,
Santa Monica, are ranked No. 5 in the nation by U.S.News World
Report, and Ronald Reagan UCLA Medical Center has been ranked
“Best in the West” for 25 consecutive years.
Modern Healthcare named him among the “50 Most Influential
Physician Executives and Leaders” in the United States for 2014. Dr.
Feinberg is a clinical professor of psychiatry in the David Geffen
School of Medicine at UCLA.
Along with his dedication to upholding the highest clinical standards
for patient care and safety, Dr. Feinberg is committed to enhancing
the patient experience. Under his leadership, patient-satisfaction
scores have reached the 99th percentile in many areas.
» MORNING KEYNOTE
NEIL SOLOMON, M.D., FACP
Vice President for Quality and Care System
Transformation
Dr. Neil Solomon joined Blue Shield of
California (BSC) as the vice president for
Quality and Care System Transformation in
April 2013. In that role, he is responsible for
designing and implementing the clinical
quality strategy for the membership. His work in quality spans
BSC’s industry leading Accountable Care Organizations, specialty
care transformation, and the use of health information technology
to enable improvements in care. Under his direction, the Quality
Department also evaluates and rewards performance among Blue
Shield’s provider community, introduces programs to improve
clinical outcomes and member experience, and reports these
findings to customers and regulators.
Prior to joining BSC, Dr. Solomon held leadership roles at Health
Net, a Western Region health plan based in California. His previous
roles included chief medical director, senior medical director for
commercial ACO development and clinical accounts management,
chair of the Medical Policy Committee and lead physician for
quality, disease management and case management.
Earlier in his career, Dr. Solomon co-founded and was the clinical
director for the Care Management Institute, Kaiser Permanente’s
internal system-wide think tank regarding population management,
disease management and quality improvement. He founded NAS
Consulting Services, a California-focused QI consulting firm that
worked with medical groups, delivery systems and health plans on
quality and service improvement. He was also CEO for the Institute
for Medical Knowledge Implementation, a nonprofit that created
interoperable clinical decision support rules and a community of
rule writers and implementers.

5. Friday, February 13, 2015 | 5
» KEYNOTE SPEAKER BIOGRAPHIES
» LUNCH MIDDAY KEYNOTE
Introduction by
ERIC ESRAILIAN, M.D., MPH
Co-Chief of the Division of Digestive Diseases,
David Geffen School of Medicine at UCLA
Dr. Esrailian is the co-chief of the Division of
Digestive Diseases at the David Geffen School
of Medicine at UCLA. Dr. Esrailian’s primary
clinical interests include gastrointestinal
endoscopy, inflammatory bowel diseases, gastrointestinal
hemorrhage and functional gastrointestinal diseases such as irritable
bowel syndrome. In addition to disease areas within gastroenterology
and internal medicine, Dr. Esrailian has a particular interest in the
development of biomedical innovations, value in healthcare, medical
education and initiatives toward patient-centered care.
In 2012, the School of Medicine awarded him the Lincy Foundation
Chair in Clinical Gastroenterology. He is closely involved in growth
strategy and strategic planning efforts for UCLA Health and the
David Geffen School of Medicine at UCLA. He also works to facilitate
community engagement with a number of other schools and
departments within the UCLA campus and its Los Angeles
community partners, and he is on the UCLA campus steering
committee for the Centennial Campaign.
PETER H. DIAMANDIS, M.D.
Chairman and CEO, X Prize Foundation
Dr. Peter H. Diamandis is an international
pioneer in the fields of innovation, incentive
competitions and commercial space. In the field
of innovation, Diamandis is chairman and CEO
of the X PRIZE Foundation, best known for its
$10 million Ansari X PRIZE for private
spaceflight. Today, the X PRIZE leads the world in designing and
operating large-scale global competitions to solve market failures.
Diamandis is also the co-founder and vice chairman of Human
Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic
and therapeutic company focused on extending the healthy human
lifespan. He is also the co-founder and executive chairman of
Singularity University, a graduate-level Silicon Valley institution that
studies exponentially growing technologies, their ability to transform
industries and solve humanity’s grand challenges.
He earned an undergraduate degree in molecular genetics and a
graduate degree in aerospace engineering from Massachusetts
Institute of Technology, and received his M.D. from Harvard Medical
School. Diamandis’ mission is to open the space frontier for
humanity. His personal motto is, “The best way to predict the future
is to create it yourself.”
» CLOSING FIRESIDE CHAT
THOMAS PRISELAC, MPH
President and CEO, Cedars-Sinai Health System
Thomas Priselac has served as president and CEO of
the Cedars-Sinai Health System since 1994 and is an
adjunct professor at UCLA Fielding School of Public
Health. Priselac was executive vice president from
1988 to 1993 and has been associated with Cedars-
Sinai since 1979.
Priselac is a past chair of the American Hospital Association (AHA) Board
of Trustees, Association of American Medical Colleges (AAMC), California
Healthcare Association and the Healthcare Committee of the Los Angeles
Chamber of Commerce. Additionally, he served on the Board of Directors of
VHA, Inc., the National Committee for Quality Healthcare, the California
Healthcare Foundation and Blue Cross of California. He lectures extensively
at professional meetings and universities on varied aspects of healthcare
delivery and leadership.
A native of Pennsylvania, he obtained a bachelor’s in biology from
Washington and Jefferson College in Pennsylvania and a master’s in
public health, health services administration and planning from the
University of Pittsburgh.
MODERATOR
LEAH VRIESMAN, PH.D.
MPH, MBA, Director, UCLA Executive Education in
Health Policy Management
Leah Vriesman is director of executive education
programs in health policy and management and is on
the faculty of UCLA’s School of Public Health in the
Department of Health Policy Management.. She
teaches strategic management of health service organizations, healthcare
marketing, international comparative health systems and, occasionally,
healthcare financial management.
Dr. Vriesman is also an adjunct professor at the University of Colorado–
Denver, teaching pharmaceutical marketing management, and an
experienced distance learning faculty member for strategic and operational
healthcare excellence and also health communication techniques.
Dr. Vriesman is also president and founder of Excel Research, LLC, a
healthcare management and policy consulting firm. Specializing in the
pharmaceutical and biotechnology industries, Excel Research primarily
conducts executive leadership, strategic analysis and market trend
projections. Prior to founding Excel Research, Dr. Vriesman was senior
director of North American Business Development within the Medical
Technology Practice at The Lewin Group, an international health policy and
research corporation, and subsidiary of Quintiles Transnational.
Dr. Vriesman received her Ph.D. in health services research from UCLA and
her MHA and MBA in strategy from the University of Minnesota-Minneapolis.

6. 6 | HBA Healthcare Conference
» PANELIST BIOGRAPHIES
» PANEL 1: PAYER/PROVIDER
With the second round of Open Enrollment almost
closed, panelists explore what’s in store for California’s
payers and providers and the new, innovative
opportunities for consumer-focused delivery.
MANEESH GOYAL (’06)
Senior Vice President of Corporate Development,
Welltok, Inc.
Maneesh Goyal joined Welltok in early 2013 as
vice president of corporate development. His
responsibilities include all partnership, alliances
and MA activity related to building out the
company’s CaféWell Connect ecosystem. Prior to
Welltok, Goyal was a managing director with Miramar Venture
Partners, a leading early stage investor focusing on the information
technology space.
With Miramar, Goyal invested in health and consumer Internet
companies and provided strategic guidance for companies moving
from the startup to growth stage. Before entering the venture world, he
was a design engineer with Broadcom, leading product development
and engineering efforts in the television, cable and satellite
communication markets.
Goyal earned a bachelor’s in biomedical engineering from Worcester
Polytechnic Institute, a master’s in electrical engineering from the
University of Southern California and an MBA from UCLA Anderson.
MARTIN SEROTA, M.D.,
Vice President and Chief Medical Officer,
AltaMed Health Services
Dr. Martin Serota joined AltaMed Health Services
as vice president and chief medical officer in May
2010. He has practiced medicine for more than 25
years, while also assuming many leadership roles,
including medical group, IPA and accountable care
organization leadership and development. He also has extensive health
information technology expertise. At AltaMed, Dr. Serota’s priorities are
to create a patient-centered organization that is focused on the patient
experience and quality outcomes. His goals are to improve operational
efficiency, especially through the use of health information technology
and innovation, thereby allowing AltaMed to care for more of the
underserved and to reduce health outcome disparities. Dr. Serota
obtained his medical degree at University of California, San Francisco,
and is board-certified in internal medicine.
ARTHUR SOUTHAM, M.D., MPH, MBA
Executive Vice President of Health Plan Operations,
Kaiser Foundation Health Plan, Inc.
Arthur M. Southam, M.D., is executive vice
president of Health Plan Operations for Kaiser
Foundation Health Plan, Inc., and Kaiser
Foundation Hospitals. Dr. Southam has national
responsibility for health plan marketing, sales,
service and administrative activities that support growth and customer
service. Before joining Kaiser Permanente in 2001, Dr. Southam was
CEO of two California-based health plans, Health Net and CareAmerica.
Dr. Southam serves as vice chairman of the Board of Directors of
CHRISTUS Health, an international Catholic health system based in
Irving, Texas. He is a member of the Board of the Council for Affordable
Quality Healthcare and on the Board of Advisors of the Fielding School
of Public Health at UCLA. He has also served as a member of the
Institute of Medicine’s Committee on the Quality of Health Care in
America. He is a past chairman of the California Association of Health
Plans. Dr. Southam received his medical degree and master’s in public
health from UCLA and his MBA from Pepperdine University.
MODERATOR
MIKE GALPER, MPH
Partner, PwC
Michael Galper is a partner in the Los Angeles
office of PwC and leads the West Coast Health
Services Practice. He has held a variety of
leadership positions over the years with the firm,
including leading the National Health Insurance
Practice. Galper’s clients include integrated health systems, managed
care companies, hospitals, physician groups and academic medical
centers. He specializes in performance improvement, cost reduction,
financial analysis, acquisition due diligence and internal control review.
Galper is an adjunct faculty member at the UCLA School of Public
Health and also serves as the chairman of the board for Hathaway
Sycamores, a child and family service agency.

7. Friday, February 13, 2015 | 7
» PANELIST BIOGRAPHIES
NINEZ PONCE, MPP, PH.D.
Director of the Center for Global and Immigrant
Health, UCLA Fielding School of Public Health
Ninez A. Ponce, MPP, Ph.D., is a professor in the
UCLA Fielding School of Public Health’s
Department of Health Policy and Management
and director of the Center for Global and
Immigrant Health. She is the principal investigator
for the California Health Interview Survey, the largest state health
survey in the nation. She led pioneering efforts in the measurement of
race/ethnicity, the implementation of the Asian ethnic oversamples
and the cultural and linguistic adaptation of the survey. A health
economist, her research contributes to the elimination of racial/ethnic
and social disparities in health and healthcare in three areas:
multicultural survey research, social penalties in health access, and
global and immigrant health.
MODERATOR
ERIC SAVITSKY, M.D.
Founder and Executive Director,
UCLA Center for International Medicine
UCLA professor of emergency medicine and
pediatric emergency medicine and director of
trauma services and education, Dr. Eric Savitsky is
the founder and executive director of the UCLA
Center for International Medicine.
An innovative educator and inventor, Dr. Savitsky has developed
multiple patent-pending inventions in the medical training and health
technology sector. He is a leading medical educator and clinician, serves
on the advisory boards of UCLA’s Center for Advanced Surgical and
Interventional Technology and Business for Diplomatic Action, and is a
member of the Pacific Council on International Policy. Dr. Savitsky
received his M.D. from the University of Florida and completed his
residency and a fellowship in pediatric emergency medicine at UCLA.
He received a bachelor’s in Russian from the University of Florida and is
conversant in English, Russian, Farsi and Spanish.
» PANEL 2: EMERGING MARKETS
A global look into new opportunities and challenges
in emerging markets across both for-profit and
nonprofit healthcare sectors.
MICHELE ABBOTT
Assistant Policy Analyst, RAND Corporation
Michele Abbott is an assistant policy analyst at
RAND and a doctoral candidate at the Pardee
RAND Graduate School. Prior to RAND, she
worked at Abt Associates on USAID-funded HIV/
AIDS and malaria prevention projects, primarily in
East Africa. At Abt, her technical focus was in
costing, cost-effectiveness and other modeling analyses to inform
health financing and policy decisions. She also analyzed a dataset
provided by the Global Fund to monetize the private sector’s in-kind
contributions to grant programs at the country level. Previously, Abbott
served as a research fellow for the Center for Health Information and
Decision Systems at the University of Maryland and holds a bachelor’s
in international business and a minor in English.
MICHAEL BURKE, M.H.A.
Director of Business Development,
UCLA Center for World Health
Michael Burke is the director of international
development for UCLA Health and the Center for
World Health. He is responsible for seeking out
and vetting potential partnership opportunities for
the medical enterprise in addition to advancing
existing partnerships and collaborations. Burke joined UCLA Health as
one of the 2012-2013 UCLA Administrative Fellows, when his worked
focused largely on value and performance improvement initiatives. He
received his undergraduate degree in finance and his master’s in health
administration from the University of Iowa. His graduate program
included an internship at Kameda Medical Center in Kamogawa-shi,
Japan, where he focused on joint commission international preparation,
pain assessment and awareness and assessment of international
patient traffic. Additionally, he worked in the department of health
management and policy at the University of Iowa, developing a strategic
plan for inpatient and outpatient geriatric service lines at University of
Iowa Hospitals and Clinics.

8. 8 | HBA Healthcare Conference
» PANELIST BIOGRAPHIES
» PANEL 3: MED-TECH BIO-DEVICE
A look at the biggest opportunities in med-tech over
the next five years, including a discussion on MEMS
technology and telehealth’s impact on patient care.
PAUL GRAND
Managing Director, RCT Ventures
Paul Grand has more than 25 years of experience
in venture capital and the founding and
management of early stage companies in
technology and healthcare. He is responsible for
sourcing RCT Ventures’ investments in medical
devices and representing RCT on the boards of its
portfolio companies. Since 1990, Grand has built, operated, recruited
management and raised financing for eight high-technology, medical
device and biotechnology companies.
Grand is actively involved in programs to encourage innovation and
technology commercialization and is a frequent speaker, moderator and
panelist at healthcare conferences. He serves as producer and emcee
for the MedTech Innovator competition, which identifies and rewards
outstanding early stage medical device companies. Grand is on the
oversight committees for the Coulter Translational Research Partnership
Programs at USC and University of Washington. He has lectured, served
as a reviewer for proof of concept and commercialization-focused
funding programs, and mentored students and scientists at numerous
universities, including UCLA, Stanford, USC, UCSF, University of Utah,
the Keck Graduate Institute and University of Colorado. Grand served as
an investment advisor to the LARTA NIH Commercialization Assistance
Program for SBIR program awardees.
ABHRA ROY, M.S., MBA (’10)
Vice President, Mechanical Engineering Material
Science Research Development, St. Jude Medical
Abhra Roy is the vice president of research and
development (leading mechanical and materials
development) at St. Jude Medical. Recognized
amongst Fortune’s most admired companies, St.
Jude Medical is a global leader in the MedTech
space, focused on delivering leading-edge cardiovascular and
neuromodulation therapy solutions. Roy has been with St. Jude for 13
years and has served in several leadership roles within research and
development, program management and operations. Roy holds an
M.E./ M.S. from Stanford and an MBA from UCLA Anderson.
MEERA SHIER (’09)
Marketing Manager, MicroVention Inc.
Meera Shier, marketing manager at MicroVention
Inc., started her career in the financial services
industry at Kayne Anderson Rudnick Investment
Management. After graduating with an MBA from
UCLA Anderson in 2009, Shier switched her focus
to medical devices and joined the marketing team at
Covidien Neurovascular as an associate product manager. In 2013, Shier
joined Microvention Inc. and currently manages a team and several
product lines.
MODERATOR
JENNIFER MCCANEY, PH.D.
Senior Fellow, UCLA Business of Science Center
Jennifer McCaney, Ph.D., is a senior fellow at the
UCLA Business of Science Center (BSC), which
sponsors the MedTech Innovation (MTI) Program
for entrepreneurship in medical device design as
well as assists university faculty and physicians in
commercializing their research through the annual Venture Team
Competition. McCaney holds a lecturer position at UCLA Anderson,
where she teaches a course on emerging technologies in healthcare,
and is an instructor for the MTI Program in the Department of
Bioengineering at UCLA. McCaney is a co-founder of Hourglass
Technologies, Inc., which developed the TRIMTM System, a nonsurgical
obesity device. She holds three patents and is the author of multiple
peer-reviewed publications. Her interests include regenerative
medicine, MEMS and microfluidics devices for biological applications,
and new venture formation. A Fulbright scholar, McCaney completed
her Ph.D. in mechanical engineering at Stanford and holds a master’s
and undergraduate degrees from MIT and the Sloan School of
Management. She also has a master’s in biomedical engineering from
the University of New South Wales. Prior to joining the BSC, McCaney
worked as a consultant to biotech and pharmaceutical companies at
Clarion Healthcare in Boston.

9. Friday, February 13, 2015 | 9
» PANELIST BIOGRAPHIES
» PANEL 4: PERSONALIZED MEDICINE
DAVID CHANG, M.D.
Executive Vice President, Research and
Development, and Chief Medical Officer,
Kite Pharma
Dr. David Chang has an industry-leading track
record of innovation within oncology drug
development. Most recently, he held senior
leadership roles during his more than decade-long
tenure at Amgen, including a stint as vice president of global
development and head of hematology-oncology. Dr. Chang spearheaded
personalized therapy strategies underlying the success of a colon cancer
drug at Amgen and ran the pivotal programs for a bispecific T-cell
engager antibody in acute lymphocytic leukemia and for a first-of-its-kind
oncolytic immunotherapy in melanoma. Dr. Chang’s areas of
responsibility at Amgen included global regulatory interactions, product
commercialization strategies, evaluation of business development
opportunities and integration of key acquisitions. Prior to joining Amgen
in 2002, Dr. Chang held dual appointments as associate professor of
medicine and microbiology, immunology and molecular genetics at the
David Geffen School of Medicine at UCLA. He obtained his bachelor’s in
biology from the Massachusetts Institute of Technology and his M.D. and
Ph.D. degrees from Stanford University. Dr. Chang also completed his
internship and residency in internal medicine at Brigham and Women’s
Hospital and his fellowship in medical oncology at Dana-Farber Cancer
Institute at Harvard Medical School, where he was a Howard Hughes
Medical Institute postdoctoral fellow.
SUDHEER DOSS, PH.D.
Director, PwC
Sudheer Doss has 13 years of experience in the
healthcare industry, focusing on operational
strategy for entry into the emerging personalized
medicine ecosystem. For the past eight years, his
industry focus has been in the bio/pharmaceutical,
diagnostics and life science tools industries. During
his tenure at PRTM/PwC, Doss has worked on a variety of projects,
including operational due diligence, business launch strategies and
various research and development innovation initiatives related to
genomic medicine. More recently, he has supported the planning and
launch of genomic medicine initiatives at several leading academic
medical and cancer centers.
Prior to joining industry, Doss worked on genomics-based biomarker
discovery during his doctorate and post-doctoral research at UCLA in the
Department of Human Genetics. His research consisted of the
development and application of genomics-based methods for the
discovery of genes underlying complex diseases such as atherosclerosis
and diabetes. Doss has pioneered computational methods that combine
areas of network theory with genetics and global gene expression data to
elucidate the pathways and genetic underpinnings of disease phenotypes.
JILL HAGENKORD, M.D.
FCAP, Chief Medical Officer, 23andMe
Dr. Jill Hagenkord joined 23andMe in 2014 and
serves as its chief medical officer, where she is
responsible for all medical affairs activities, serving as
the company liaison to physician, medical, genetics
and research industry groups. Dr. Hagenkord also
oversees laboratory, shipping and fulfillment
operations for the company.
Previously, she served as senior vice president of medical strategy for
InVitae Corporation, a genetics information company. Prior to joining
Invitae, she served as chief medical officer and senior vice president at
Complete Genomics, Inc.
Dr. Hagenkord is a board-certified molecular genetic pathologist. She
received her M.D. from Stanford University in 1999.
ALEXANDER HOFFMANN, PH.D.
Professor, Microbiology and Immunology, UCLA
Director, Institute for Quantitative and
Computational Biosciences
Alexander Hoffmann is the Thomas M Asher
Professor of Microbiology and Immunology at
UCLA and the founding director of the Institute for
Quantitative and Computational Biosciences.
Before joining UCLA in 2014, he was professor of biochemistry at
University of California, San Diego, where he founded the San Diego
Center for Systems Biology, co-founded the BioCircuits Institute and
transformed the graduate program in bioinformatics and systems biology
to span the computational biosciences from biomedical informatics to
quantitative biology. He holds degrees in physics and zoology (B.A.,
Cambridge University), biochemistry and molecular biology (Ph.D.,
Rockefeller University) and owes his training to Robert Roeder and David
Baltimore, as well as his many computational biology students.
MODERATOR
ERIC VILAIN, PH.D.
UCLA Professor of Human Genetics,
Pediatrics and Urology at UCLA
Co-Director, Institute for Society and Genetics
Chief of Medical Genetics, UCLA
Eric Vilain, M.D., Ph.D., earned his M.D. from the Paris
Children’s Hospital Necker, his Ph.D. from the Pasteur
Institute in Paris, France, and then completed a postdoctoral fellowship in
medical genetics at UCLA. He is a professor of human genetics, pediatrics
and urology in the David Geffen School of Medicine at UCLA, the chief of
medical genetics in the Department of Pediatrics, the co-director of the
Institute for Society and Genetics and the co-director of the Clinical
Genomics Center. His laboratory explores the genetics of sexual
development, focusing on genetic and environmental determinants of what
makes men and women different in their anatomy, behavior and
susceptibility to disease. His research program has been continuously
supported by several grants from the National Institutes of Health, and he
has published extensively in the field of sexual development. He is a fellow of
the American College of Medical Genetics.
In his recent State of the Union address, President Obama asserted that personalized
medicine (aka “precision medicine”) will “bring us closer to curing diseases like cancer and
diabetes… and keep ourselves and our families healthier.” In this panel, academic and industry
experts discuss opportunities and challenges in the future of personalized medicine.

10. 10 | HBA Healthcare Conference
» PANELIST BIOGRAPHIES
» PANEL 5: MOBILE HEALTH
ILANA MUHLSTEIN
Registered Dietitian Nutritionist,
UCLA Bruin Health Improvement Program
Ilana Muhlstein, R.D., is a registered dietitian
nutritionist with a private practice in Los
Angeles. She also works at UCLA, where she
meets with occupational health patients and
leads the Bruin Health Improvement Program.
Muhlstein acts as a nutrition consultant for several companies
including Whole Foods Market, Curves, H2 Wellness Inc., and RIPE.
In addition, she hosts and produces her own web TV series, titled
Living Healthy Living Well on EmpowerMe.tv, and acts as the
nutrition expert adviser for AE’s upcoming new series, Fit2Fat2Fit.
In addition, Ilana has worked in corporate wellness visiting large
corporations and improving their in-house food offerings such as
PIMCO, the Roll Company, Western Assets and Herbalife. She
completed her Bachelors of Science degree from University of
Maryland, and her Masters degree at North Eastern University.”
KOUROSH PARSAPOUR, M.D., MBA
CEO, personalRN
Dr. Kourosh Parsapour is co-founder and CEO of
personalRN, a digital health startup providing
disease-specific inpatient education that is
personalized to the needs of patients and their
caregivers. He has over 15 years of clinical
experience in pediatrics, emergency medicine and
critical care. Dr. Parsapour’s background in technology-enabled
healthcare solutions started with his first faculty appointment at
University of California, Davis in 2005. Since then, he has worked with
clinicians, administrators and health policymakers to support the use
and advancement of telehealth. His research and numerous publications
in telemedicine culminated in his first startup, Telepeds. Specialists on
Call, the leading provider of tele-stroke services, acquired Telepeds
within its first year. Subsequent to his successful exit, he obtained his
Healthcare Executive MBA from University of California, Irvine and
remains very passionate about using innovative and relevant technology
to improve the quality and accessibility of affordable healthcare.
DAVID J. WHELAN (’02)
Co-Founder, STEMP Inc.
David J. Whelan is a strategy consultant, operating
executive and advisor building businesses and
inspiring entrepreneurs at the intersection of
technology, health and wellness. He is currently
developing two digital health ventures, the
STEMP™ Smart Temperature Patch and a stealth
data analytics company. Recent engagements include a multiyear
strategic and financial plan for a leading synthetic biology organization
and a commercialization strategy for a hospital-developed cancer
diagnostic. He helped launch New York Genome Center, a unique not-
for-profit scientific research institute. He was part of the team at 24
Hour Fitness that introduced an early consumer fitness wearable. A
former retained executive search consultant, Whelan began his career
with a biotechnology incubator in San Francisco. He holds an MBA with
honors from UCLA Anderson and a B.S. in symbolic systems from
Stanford University. He also studied at London Business School and
Carnegie Mellon University.
MODERATOR
MARK SCHWARTZ
Founder, Launchpad Digital Health
Mark Schwartz is a founder, general partner and
managing director at Launchpad Digital Health
(LDH), a seed-stage venture fund, providing co-
location, mentoring and networking services in
San Francisco. LDH partners with dynamic
management teams to build great, lasting companies. Prior to LDH,
Schwartz spent more than 15 years in technology hardware, software,
medical devices and life sciences. He co-founded Fabrinet, which
provided optical technology, components for laser eye and skin
surgeries, and anesthesia monitoring. as Bus Dev, GC, chief strategy
officer; CFO 8 years and at IPO on NYSE in 2010 until 2012. He recently
advised healthcare startups Pepex (glucose monitoring) and TIMMES
(teleradiology, medical imaging data) and co-founded and advises
Precision Converting Solutions (medical devices). Schwartz began his
career as a corporate lawyer in Silicon Valley, specializing in mergers
and acquisitions, licensing and other strategic transactions.
The panel will offer a perspective on the future landscape of mobile
health solutions, and discuss how physicians plan to integrate and
manage health information collected by their patients, the impact of
regulation and the application of mobile health in emerging markets.

11. Friday, February 13, 2015 | 11
» PANELIST BIOGRAPHIES
» PANEL 6: POLICY
After the election of a Republican majority to the U.S.
Congress, this discussion will center on the future of
the Affordable Care Act and other healthcare policy
issues facing the United States today.
ALBERT LOWEY-BALL, PH.D.
Health Economics and Medicaid Advisor,
UC Berkeley School of Public Health
Albert Lowey-Ball is a health economics and
Medicaid advisor to the California Program on
Access to Care (CPAC) at UC Berkeley School of
Public Health. His responsibilities include analyses of
Medicaid (Medi-Cal) and managed care expansion
and the Affordable Care Act’s (ACA, CoveredCA) implementation issues.
CPAC’s mission is to address quality, access and cost issues faced by
underserved communities in California. He is also president of Albert
Lowey-Ball Associates, Inc. (ALBA), a health economics consulting firm.
His primary clients are investment banks and venture capital firms and a
network of independent practice associations, clinics, medical groups and
hospitals. His work at CPAC focuses on the analyses of California’s health
policy options within the framework of the ACA, including those related to
healthcare mergers, rates and essential health benefits; impacts of
Medicaid and managed care expansion; immigrant and rural healthcare
coverage; viability of the Safety Net and implementation; and operation of
health insurance exchanges. Lowey-Ball played a pioneering role in the
development of Medi-Cal managed care plans and set up the first
successful County Organized Health System — the Santa Barbara Health
Initiative (CenCal Health Plan) — in the state. He also played a key role in
establishing Care 1st Health Plan (now part of Health Net). He is a graduate
of Rice and Georgetown and the University of Maryland and served as
faculty in the masters programs in health policy and economics at the
University of San Francisco for 21 years.
JONATHAN FIELDING, M.D., MPH, MBA
Director and Professor-in-Residence,
UCLA Fielding School of Public Health
Dr. Jonathan E. Fielding, M.D., MPH, MBA has more
than 30 years of experience working in various
capacities in the areas of public health. He has
recently retired after 16 years as the director of the
Los Angeles County Department of Public Health.
Since 1979, Dr. Fielding has been a professor at the Schools of Public Health
and Medicine at UCLA. From 1979 through 1984, he was the co-director for
the Center for Health Enhancement, Education and Research. He chairs the
HHS Secretary’s expert advisory group on the 2020 Healthy People Project,
chairs the U.S. Community Preventive Services Task Force and is the editor
of the Annual Review of Public Health. His current research interests are
health impact assessment and forecasting future health. He received his
medical degree and master’s in public health from Harvard University and
an MBA from the University of Pennsylvania’s Wharton School of Business.
WENDY SCHIFFER, MSPH
Director of Strategic Planning, L.A. Care Health Plan
Wendy Schiffer is the director of strategic planning
for L.A. Care Health Plan, the nation’s largest public
plan. L.A. Care provides care to more than 1.6
million members. Schiffer’s experience
encompasses health services planning; health
insurance outreach, enrollment and retention; and
enterprise-wide planning activities. Prior to joining L.A. Care, she served
as director of Planning, Evaluation and Development for the Los Angeles
County Department of Public Health, where she was responsible for the
analyses of hospital demand; ambulatory care resource allocation;
system planning under the County’s 1115 Waiver Medicaid Waiver; and
HIV service planning. Schiffer holds an M.S. and B.A. in public health and
history/sociology, respectively.
MODERATOR
WESLEY YIN, PH.D.
Associate Professor, UCLA
Wesley Yin is an associate professor in the Luskin
School of Public Affairs and UCLA Anderson, and
is a faculty research fellow at the National Bureau
of Economic Research. Yin’s research interests are
in the areas of health, economic development,
industrial organizations and public finance. His current research studies
the relationship between economic growth and the formation of private
markets; and how information, income and competitive forces impact
the delivery of healthcare. Prior to coming to UCLA, Yin served as acting
assistant secretary of economic policy at the Department of Treasury,
and as a senior economist in the White House Council of Economic
Advisers. He also taught at Boston University and the University of
Chicago, and was a Robert Wood Johnson Scholar in Health Policy at
Harvard University.

12. 12 | HBA Healthcare Conference
» PANELIST BIOGRAPHIES
BRIAN WILLIAMS
Director, PwC
Brian Williams is a director at PwC who advises
healthcare executives on strategy, innovation and
corporate and entrepreneurial ventures. He has
nearly 20 years of investment, business
development and strategy expertise within
healthcare. His work at PwC provides senior
executives with insights on market entry strategies, business model
innovation and mHealth and eHealth strategy development and
implementation. Prior to joining PwC, Williams served as an executive
for two healthcare firms, including one early stage company where he
quadrupled revenue in three years. He also drove industry acceptance
and market growth of a venture-backed, Silicon Valley-based SaaS-
deployed pharmaceutical data management and performance analytics
firm. As an investor, Williams co-founded two top decile performing
private equity funds as ranked by PwC’s MoneyTree report, whose
investments included devices and diagnostics.
MODERATOR
BILL COMANOR, PH.D.
Professor of Health Policy and Management,
Professor of Economics, UC Santa Barbara
Director, Research Program on Pharmaceutical
Economics and Policy, UCLA
William Comanor is a professor of health policy
and management and a professor of economics at
the University of California, Santa Barbara. At UCLA, he is director of
the Research Program on Pharmaceutical Economics and Policy and
also organizes a seminar by the same name. Comanor received his
Ph.D. in economics from Harvard University in 1964. Since completing
his dissertation on “The Economics of Research and Development in the
Pharmaceutical Industry,” he has written and lectured on various topics
in this area and founded the Research Program he now directs. From
1991 through 1993, he served on the advisory panel of a federal
government study on pharmaceutical research and development, and
from 1978 through 1980, was chief economist and director of the
Bureau of Economics at the U.S. Federal Trade Commission in
Washington, D.C.
» PANEL 7: BIOPHARMA
After a year of biotech acquisitions, exploding stock
prices, changes in government regulations and a
globalizing biopharma market, what is in store for the
life sciences industry?
STEPHANIE ASTROW, PH.D., MBA
Vice President of Research and Development,
Response Genetics
Stephanie Astrow is vice president of research and
development for Response Genetics, a company
focused on the development and
commercialization of clinical diagnostic tests for
cancer. In this role, she identifies opportunities for
new products, technologies and acquisitions to drive revenue in a highly
competitive market sector. Prior to joining Response Genetics, Astrow
was scientific director for oncology at Quest Diagnostics. At Quest, she
played a key role in expanding business by introducing new assays and
services as well as coordinating development strategy for companion
diagnostics with key pharmaceutical companies. Prior to Quest, Astrow
served as vice president of oncology at Pathway Diagnostics, and vice
president and scientific director at Impath, Inc. Astrow received a
bachelor’s in biology and medicine at Brown University and her Ph.D. in
molecular and cell biology from the University of California, Berkeley. She
also holds an MBA from Pepperdine University.
GUNJAN (MITAL) THIAGARAJAH (’05)
Director, Amgen
Gunjan Thiagarajah is currently the marketing
promotions lead for Vectibix in the oncology
business unit. In this role, she has overseen the
label expansion and growth of this biomarker
driven therapeutic.
Prior to this role, she worked in payer and value
marketing. She led a team that developed and executed the payer
strategies for key Amgen products in the nephrology and oncology
therapeutic areas. This included the creation of health-economic and
value (FDAMA114) marketing resources. In this role, she also led the
payer biosimilar strategy.
Thiagarajah joined Amgen in 2005 via the Commercial Leadership
Program (CLP), starting as a sales representative in nephrology before
transitioning to marketing roles. Early marketing experience included
Enbrel Rheumatology as well as Access, where she developed the
ENBREL patient support program. Prior to Amgen, Thiagarajah worked
with Deloitte Consulting, where she enhanced business processes for
claims and membership departments for large health insurance
providers, designed new products and led HIPAA compliance initiatives.
She has a bachelor’s in electrical engineering from Rutgers University
and an MBA from UCLA Anderson.

13. Friday, February 13, 2015 | 13
CAROL LEE THORPE, MBA
Vice President of Programs and Services
St. Barnabas Senior Services
Carol Lee Thorpe is vice president of programs and
services for St. Barnabas Senior Services, an
organization providing a continuum of innovative
services that empower a diverse community of
elders to live well, feel well and age well. She is
responsible for strategic oversight of social services, healthcare,
nutrition, transportation, wellness and longevity programs, community
outreach and civic engagement. Thorpe also provides staff support to
the Los Angeles Aging Advocacy Coalition and serves as an advisor for
the implementation of California’s Coordinated Care Initiative.
Thorpe received her MBA from Pepperdine University in 1991.
Throughout her career, she has held leadership positions with human
services organizations and led the development of innovative healthcare
and education programs.
Thorpe has devoted her career to providing creative leadership to
health, social service and community service initiatives on behalf of
vulnerable populations in California.
MODERATOR
ARASH NAEIM, M.D., PH.D.,
Chief Medical Officer of Clinical Research and
Geriatric Oncologist, UCLA Health
Dr. Arash Naeim is a health professional whose
career has spanned a combination of health
services, informatics, health policy and quality of
care issues. He currently serves as UCLA’s chief
medical officer for clinical research and associate professor of medicine
in the divisions of hematology-oncology and geriatric medicine at the
David Geffen UCLA School of Medicine. He is also director of two
programs, the Geriatric-Oncology Research and Training Program and
Hematology-Oncology Fellowship Program at UCLA. Additionally, Dr.
Naeim holds multiple key organizational roles on campus, in the Cancer
Center, within the Health System and for the Department of Medicine.
Dr. Naeim earned his B.S. in biochemistry and M.D. at the University of
California, and received a Ph.D. in public policy from the RAND
Corporation. His primary research focus is on breast cancer and his
other research interests include outcomes research, cost-effectiveness
analysis, modeling of health and frailty and clinical trial design.
» PANELIST BIOGRAPHIES
» PANEL 8: BABY BOOMER SILVER TSUNAMI
SANDY ATKINS, MPA
Vice President of Strategic Initiatives,
Partners in Care Foundation
Sandy Atkins has over 30 years of experience
planning and managing services for chronically ill
adults. She is currently the vice president of
strategic initiatives at Partners in Care Foundation,
in charge of HomeMeds dissemination, consulting,
evaluation and new initiative development. Prior to joining Partners in
Care, Atkins served as executive director of Hospice of Pasadena. At the
USC Andrus Gerontology Center, she directed the Center for Long Term
Care Integration, a state-funded effort to help counties integrate
Medicare and Medicaid systems (both medical and long-term care
services) for the aged, blind and disabled population. Atkins also directed
the STARS Minnesota Rural Elder Services Community Initiative to help
small towns plan services for their rapidly aging populations. Before that,
she was administrator of several California continuing care retirement
communities. Atkins has a master’s of public administration in long-term
care administration, with a certificate in gerontology, from the University
of Arizona, and a B.A. in Spanish from SUNY Buffalo.
SCOTT KAISER, M.D.
Chief Innovation Officer,
Motion Picture Television Fund
Dr. Scott Kaiser is a practicing geriatrician and
chief innovation officer at the Motion Picture
Television Fund (MPTF), which provides services,
support and assistance to the entertainment
industry community. He is an advocate for the
improvement of aging services and geriatric care with a focus on better
health and well-being through a community-oriented approach to the
care of older adults. He believes in looking beyond healthcare to meet
people where they are and where health happens: in their daily lives,
with their friends and families, in their communities.
Dr. Kaiser received his medical degree from the Keck School of Medicine
of USC. He went on to train within the Lawrence Family Medicine
Residency, a program dedicated to the care of underserved populations.
Following residency, he joined the Harvard Geriatric Medicine
Fellowship, where he refined his clinical skills and began to apply his
interest in health promotion to an older adult population while initiating
research exploring the psychology of health behavior change. To further
his expertise in this field, Dr. Kaiser returned to Los Angeles and joined
the UCLA/VA Primary Care and Health Services Research Fellowship,
where he served as a health media fellow. In this role, Dr. Kaiser
partnered with the City of Los Angeles Department of Aging to produce
broadcast media projects aimed at directly addressing the needs of older
adults and ultimately improving their health and quality of life, including
“On The Move,” a series following the lives of 12 L.A. seniors as they take
on new challenges to become active, get fit, embrace a healthy lifestyle
and enjoy all the rewards of their transformations.
By 2029, 20% of the US population will be over the age of 65 i.e. 1 in 5
Americans will be age 65 or older. What are the healthcare needs of the
aging population? How is the healthcare system equipped to address the
challenges imposed by the aging population?

14. 14 | HBA Healthcare Conference
» HBA CONFERENCE PANEL LEADS
PANEL 1: Payer/Provider — Alex Carey
PANEL 2: Emerging Markets — Margaret Threadgill Joanne Zhang
PANEL 3: Medtech Biodevice — Catherine Chen Mona Mohindra
PANEL 4: Personalized Medicine — Daniel Croymans, Kevin Shah, Brad Turner
PANEL 5: Mobile Health — Ankur Agarwal Deb Dab
PANEL 6: Policy — Caitlyn Penny Brendon Pezzack
PANEL 7: Pharma — Adam Foley Ines Reygadas
PANEL 8: Baby Boomer Silver Tsunami — Tanu Bose Bryan Pezeshki
http://bit.ly/1KwgAvT
Conference attendees recieve 20% discount
on a 23andMe kit. Follow the link above!

15. BlueShieldofCaliforniaisanindependentmemberoftheBlueShieldAssociationA47869(1/15)
Blue Shield of California is proud to support
the UCLA Anderson School of Management’s
Healthcare Business Association (HBA).
Guided by our not-for-profit values,
we are committed to influencing positive
change in our community and ensuring
access to affordable, high-quality health
care for all Californians.
We are very pleased to be a sponsor
of this year’s “Modernizing Healthcare for
the New Age” conference.
for care, not profit.TM

16. George Buckley, Conference Chair
Subodh Kolla, HBA President Sponsorship Chair
Joel Lanzaga, Logistics Operations Co-Chair
Steve Schumsky, Logistics Operations Co-Chair
Ben Brockman, Marketing Chair
Fabienne Wen, Marketing Director
Rachel Newman, Business Development Co-Chair
Brendon Pezzack, Business Development (Products) Co-Director
Kevin Shah, Business Development (Products) Co-Director
Martin Wan, Business Development Co-Chair
Brian Ouyang, Business Development (Services) Co-Director
Bryan Pezeshki, Business Development (Services) Co-Director
Daniel Croymans, Outreach Chair
Brad Turner, Outreach Director
Kristin Andreassen, External Outreach Chair
Chad Kunert, External Outreach Director
Miao Wang, Information Technology Chair
Wenyuan Wu, Information Technology Director
UCLA Anderson School of Management
110 Westwood Plaza
Los Angeles, CA 90095-1481
andersonhba.com
PLATINUM
SPONSORS
HBA CONFERENCE TEAM:
GOLD:
BLUE:
CAMPUS AFFILIATES:
Special thanks to Easton Technology Development Program, Edwards Lifesciences, PwC and UCLA Anderson Office of the Dean